Marshman Fund Trust II 4
4 · Harmony Biosciences Holdings, Inc. · Filed Aug 25, 2020
Insider Transaction Report
Form 4
Marshman Fund Trust II
10% Owner
Transactions
- Conversion
Common Stock
[F1]2020-08-21+4,026,784→ 10,958,547 total - Conversion
Series A Preferred Stock
[F1][F2]2020-08-21−25,983,571→ 0 total→ Common Stock (4,026,784 underlying)
Footnotes (2)
- [F1]Each share of preffered stock automatically converted on a 8.215-for-1 basis into common stock upon the closing of the Issuer's initial public offering.
- [F2]Includes 983,571 shares received upon the payment of an in-kind dividend on the Series A Preferred Stock on August 21, 2020.
Signature
/s/ Stephanie Wisdo, as Attorney-in-fact for Charles Harris, Authorized Signatory|2020-08-25